Myriad Genetics director Daniel M. Skovronsky resigns effective June 17, 2026

MYRIAD GENETICS INC

Daniel M. Skovronsky resigned from Myriad Genetics board effective June 17, 2026.
Resignation was not due to any disagreement with the company or its operations.
Myriad Genetics (MYGN) filed Form 8-K on June 23, 2026 to report the departure.
Skovronsky served as a director prior to resignation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.